Table 3.
Multivariable Cox regression analysis of predictors of MACE
All patients N = 309 | Patients without MACE N = 267 | Patients with MACE N = 42 | *P-value | |
---|---|---|---|---|
CSBF at rest (mL/min) | 92 ± 38 | 87 ± 34 | 121 ± 48 | < 0.001 |
CSBF during ATP infusion (mL/min) | 234 ± 81** | 230 ± 81** | 238 ± 84** | 0.58 |
ΔCSBF (mL/min) | 140 ± 67 | 143 ± 68 | 117 ± 53 | 0.016 |
Coronary flow reserve | 2.7 ± 0.9 | 2.8 ± 0.9 | 2.0 ± 0.4 | < 0.001 |
Coronary flow reserve < 2.0 | 55 (17%) | 30 (11%) | 25 (60%) | < 0.001 |
Data are expressed as mean ± standard deviation or number (%)
* P-values represent the difference between patients with and without MACE. ** P < 0.05 vs. CSBF at rest
ΔCSBF = CSBF during ATP infusion – CSBF at rest. Coronary flow reserve = CSBF during ATP infusion / CSBF at rest × 100
ATP adenosine triphosphate, CSBF coronary sinus blood flow, MACE major adverse cardiac events